{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-004498","form_type":"8-K","ticker":"PMDI","cik":"0000806517","company_name":"PSYCHEMEDICS CORP","filed_at":"2023-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.689691+00:00","generated_at":"2026-06-13T08:31:08.553595+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Psychemedics CEO Raymond Kubacki to retire; Brian Hullinger named successor as President/CEO","bullets":["Raymond Kubacki and director Fred Weinert retire effective Aug 17, 2023; controller William Norris resigns effective July 21.","Brian Hullinger appointed President/CEO effective Aug 17; base salary $375,000, target bonus $190,000 (2023 guaranteed).","Hullinger receives inducement option for 300,000 shares in three tranches: time-based and VWAP-linked targets.","Michael Weisenhoff appointed principal financial/accounting manager (salary $135,000) effective July 20.","Kubacki enters retirement agreement with consulting at $5,000/week; his 44,000 stock units fully vest on consulting end."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-004498","json":"https://secwatch.observer/filing/0001171843-23-004498.json","markdown":"https://secwatch.observer/filing/0001171843-23-004498.md","text":"https://secwatch.observer/filing/0001171843-23-004498.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/0001171843-23-004498-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/f8k_071323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:31:08.553595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4598f7b0cf","claim":"William Norris resigned as Controller at PSYCHEMEDICS CORP.","evidence_excerpt":"On July 12, 2023, William Norris, the Company’s Controller, resigned from such position, and otherwise as an officer of the Company, effective July 21, 2023 to take a position with a home healthcare technology company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/0001171843-23-004498-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Controller"}],"fact_type":"executive_change"},{"claim_id":"652e9d7ec8","claim":"Fred J. Weinert retired as director at PSYCHEMEDICS CORP.","evidence_excerpt":"On July 12, 2023, Fred J. Weinert, a director of the Company, notified the Company that he will retire as a director effective August 17, 2023 coincident with the Annual Meeting of Stockholders on such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/0001171843-23-004498-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"6f8c388bb9","claim":"Raymond C. Kubacki retired as Chairman, Chief Executive Officer and President at PSYCHEMEDICS CORP.","evidence_excerpt":"On July 12, 2023 Raymond C. Kubacki, the Company’s Chairman, Chief Executive Officer and President notified the Company that he will retire as Chairman Chief Executive Officer and President effective August 17, 2023 coincident with the Annual Meeting of Stockholders on such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/0001171843-23-004498-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chairman, Chief Executive Officer and President"}],"fact_type":"executive_change"},{"claim_id":"86a5376d5d","claim":"Brian Hullinger was appointed as President and Chief Executive Officer at PSYCHEMEDICS CORP.","evidence_excerpt":"On July 12, 2023, the Company announced Brian Hullinger as the new President and Chief Executive Officer of the Company, to take effect on August 17, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/0001171843-23-004498-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"bdc514a69b","claim":"Michael Weisenhoff was appointed as principal financial and accounting manager at PSYCHEMEDICS CORP.","evidence_excerpt":"On July 13, 2023, the Company appointed Michael Weisenhoff, Assistant Controller of the Company, as the Company’s principal financial and accounting manager, to take effect as of July 20, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/0001171843-23-004498-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"principal financial and accounting manager"}],"fact_type":"executive_change"},{"claim_id":"e193a0e1b3","claim":"Brian Hullinger was appointed as director at PSYCHEMEDICS CORP.","evidence_excerpt":"He has also been nominated to be elected as a director of the Company at the Annual Meeting of Stockholders to be held on August 17, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/806517/000117184323004498/0001171843-23-004498-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}